|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1998-5-28
|
|
pubmed:abstractText |
A regimen of multi-drug chemotherapy alternating with split course hyperfractionated radiation therapy (HFRT) was adopted for the treatment of patients with rhabdomyosarcoma (RMS). The purpose of this treatment regimen was to allow for the timely delivery of radiation and chemotherapy, reduce treatment-related toxicity, and improve compliance.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0098-1532
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
332-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9589081-Adolescent,
pubmed-meshheading:9589081-Adult,
pubmed-meshheading:9589081-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9589081-Child,
pubmed-meshheading:9589081-Child, Preschool,
pubmed-meshheading:9589081-Combined Modality Therapy,
pubmed-meshheading:9589081-Dose Fractionation,
pubmed-meshheading:9589081-Humans,
pubmed-meshheading:9589081-Infant,
pubmed-meshheading:9589081-Rhabdomyosarcoma,
pubmed-meshheading:9589081-Survival Rate
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Results of alternating chemotherapy and hyperfractionated radiation therapy in childhood rhabdomyosarcoma.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
